Clinical trial
Riluzole to Treat Major Depression
NCT00026052 · National Institute of Mental Health (NIMH), NIH · Completed
Key facts
| NCT number | NCT00026052 |
|---|---|
| Title | Riluzole to Treat Major Depression |
| Official title | An Investigation of the Antidepressant Efficacy of an Antiglutamatergic Agent With Neurotrophic Properties in Major Depression |
| Lead sponsor | National Institute of Mental Health (NIMH), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Depression |
| Intervention type | Drug |
| Interventions | riluzole |
| Enrollment | 31 |
| Start date | Nov 1, 2001 |
| Completion | Apr 1, 2003 |
| First posted | Nov 9, 2001 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: